● Recruiting

Study of TJ033721 (Givastomig) in Subjects With Advanced or Metastatic Solid Tumors

Condition: Solid Tumor · Advanced Cancer · Metastatic Cancer · Sponsor: I-Mab Biopharma US Limited

PhasePhase 1

Planned participants330

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is an open label, multi-center, multiple dose Phase 1 study to evaluate the safety, tolerability, MTD PK, and PD of TJ033721 (givastomig) in subjects with advanced or metastatic solid tumors.

This description comes directly from the study's public registry record.

Talk to the study team

Clinical Development · (240) 745-6330 · us.info@imabbio.com

Always discuss trial participation with your own doctor first.

Locations (21)

Stern Center for Cancer Clinical Trials and Research	Orange, California, United States	Recruiting
UCHealth Cancer Care - Anschutz Medical Campus	Aurora, Colorado, United States	Recruiting
Horizon Oncology Research, LLC.	Layfayette, Indiana, United States	Completed
Mass General Hospital	Boston, Massachusetts, United States	Recruiting
Rutgers Cancer Institute of New Jersey	New Brunswick, New Jersey, United States	Completed
NYU Langone	New York, New York, United States	Recruiting
Memorial Sloan Kettering Cancer Center	New York, New York, United States	Recruiting
Carolina BioOncology Institute	Huntersville, North Carolina, United States	Completed
Vanderbilt-Ingram Cancer Center	Nashville, Tennessee, United States	Completed
Mary Crowley Cancer Research	Dallas, Texas, United States	Completed
UW Carbone Cancer Center	Madison, Wisconsin, United States	Recruiting
The Second Hospital of Anhui Medical University	Hefei, Anhui, China	Withdrawn

+ 9 more locations — full list on the registry record.

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT04900818